Elanco Animal Health Incorporated (ELAN)
BiotechSign Signal Grade
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Pipeline Overview
- Therapeutic Focus
- Biotech / Pharmasrc
Clinical Trial Activity
(ClinicalTrials.gov aggregate)
ClinicalTrials.gov aggregate as of 2026-10-13. ClinicalTrials.gov
Dilution Risk
LOW DILUTION RISKDilution score: 10/100 (LOW), 47.5 months cash
Derived from verified regulatory filings. Measures dilution exposure from warrants, convertibles, and offering history. DilutionWatch SEC-derived score
Short Interest
Short interest: 7.54% of float, squeeze risk: MODERATE
FINRA short sale data. FINRA short interest
Recent News & SEC Filings
- Q2 Earnings Outperformers: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Stocks
- One Health Innovation District Breaks Ground on One Health Research Institute, Anchored by Purdue University and Elanco Animal Health
- 2 Cash-Producing Stocks for Long-Term Investors and 1 Facing Headwinds
- Elanco Animal Health Eyes Growth, Deleveraging as Quattro and Zenrelia Gain Ground
- Elanco to Participate in BofA Securities Global Healthcare Conference 2026
- Expanding Tick and Itch Season Supports Momentum in Elanco Innovation, Meeting Pet Owner Demand for Health and Wellness Care
- Is Elanco Animal Health (ELAN) Undervalued As Growth Expectations Meet A Recent Pullback?
- Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Recent Publications
- 2015 AAHA/AAFP pain management guidelines for dogs and cats. — J Feline Med Surg 2015 Mar PMID 25701863
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for Elanco Animal Health Incorporated.
Full ELAN Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.